Fu, X.; Wang, J.; Cai, H.; Jiang, H.; Han, S.
Correction: Fu et al. C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction. Pharmaceuticals 2022, 15, 471. Pharmaceuticals 2025, 18, 985.
https://doi.org/10.3390/ph18070985
AMA Style
Fu X, Wang J, Cai H, Jiang H, Han S.
Correction: Fu et al. C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction. Pharmaceuticals 2022, 15, 471. Pharmaceuticals. 2025; 18(7):985.
https://doi.org/10.3390/ph18070985
Chicago/Turabian Style
Fu, Xiaoxiao, Jing Wang, Huaying Cai, Hong Jiang, and Shu Han.
2025. "Correction: Fu et al. C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction. Pharmaceuticals 2022, 15, 471" Pharmaceuticals 18, no. 7: 985.
https://doi.org/10.3390/ph18070985
APA Style
Fu, X., Wang, J., Cai, H., Jiang, H., & Han, S.
(2025). Correction: Fu et al. C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction. Pharmaceuticals 2022, 15, 471. Pharmaceuticals, 18(7), 985.
https://doi.org/10.3390/ph18070985
